Consumer products giant Clorox (NYSE: CLX) beat Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q1 2027), with sales up 33.3% year on year to $1.91 billion. Its non-GAAP profit of $1.55 per share was 44.6% above analysts’ consensus estimates.

Is now the time to buy CLX? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Clorox’s third quarter results were well received by the market, supported by substantial year-on-year revenue growth and non-GAAP profit well above Wall Street expectations. Management attributed the quarter’s performance to a combination of strong execution across its core categories, favorable timing benefits, and progress in regaining market share, particularly in home care and Hidden Valley Ranch. CEO Linda Rendle highlighted, “the underlying trajectory of the business continues to move in the right direction, with steady progress in organic sales growth and market share.”

Looking ahead, Clorox’s guidance is shaped by ongoing cost inflation and a continued focus on margin recovery through balanced pricing, productivity, and innovation initiatives. Management expects the benefits of cost-saving actions and targeted price increases to become more pronounced in the back half of the year. CFO Luc Bellet noted, “the majority of the margin recovery is still going to come from productivity and cost savings,” while also emphasizing the role of new product launches and enhanced brand superiority in supporting future growth.

Key insights from management’s remarks

Management cited a mix of strong category execution, cost-saving initiatives, and targeted pricing as key factors behind the quarter’s results, while acknowledging persistent input cost pressures and evolving consumer behaviors.

• Category share gains: Clorox saw market share improvement in home care, driven by innovation and effective back-to-school merchandising. Hidden Valley Ranch also posted strong share gains despite challenges in the broader category, while Glad and Burt’s Bees held steady. However, the litter business continued to weigh on overall share performance, though signs of improvement were noted.

• Productivity and cost savings: The company delivered one of its highest quarterly cost savings on record, supported by enhanced productivity engines and data-driven capabilities like revenue growth management (RGM) and design-to-value initiatives. Management emphasized that these tools contributed meaningfully to margin resilience despite inflationary headwinds.

• GOJO Industries integration: The integration of GOJO Industries (maker of Purell) is progressing faster than expected, with management now having full visibility to the $50 million synergy target and some benefits arriving earlier than initially planned. The acquisition has also contributed favorably to price mix within the Health and Wellness segment.

• Pricing actions: Targeted price increases were implemented across all reporting segments, notably in Glad trash bags to offset resin cost inflation. Additional pricing is planned for the back half of the year, timed with innovation launches and where commodity pressures are most acute.

• Consumer value-seeking: Shifting consumer behaviors—such as buying in bulk, delaying purchases, and opting for larger or smaller pack sizes—have persisted, requiring Clorox to remain agile in its merchandising and pricing strategies to maintain competitiveness and share.

Drivers of future performance

Clorox’s outlook emphasizes strategic pricing, productivity gains, and innovation as the main levers for margin and revenue growth, while navigating ongoing inflation and shifting consumer habits.

• Cost inflation mitigation: Input cost pressures, particularly in commodities like resin and transportation, remain elevated and are expected to be most acute in the first half of the year. Management plans to address these through continued productivity improvements, targeted pricing, and margin management strategies, with the impact of mitigation actions increasing in the second half.

• Innovation and new product launches: A robust pipeline of product innovation is slated for the back half of the year, with most launches concentrated in Q3 and Q4. Management believes these new products, many of which build on successful existing platforms, will drive category growth and support market share gains.

• GOJO Industries synergy realization: The accelerated capture of cost and operational synergies from the GOJO Industries acquisition is expected to contribute positively to both gross margin and SG&A efficiency, supporting Clorox’s margin recovery and capacity for ongoing investment in brand superiority.

Catalysts in upcoming quarters

Looking forward, the StockStory team will be monitoring (1) the pace and effectiveness of new product launches and their impact on share trends, (2) the realization and timing of cost savings and synergies from the GOJO Industries integration, and (3) the company’s ability to offset ongoing commodity and logistics inflation through strategic pricing and productivity. Progress in the litter category and signs of margin recovery in the second half will also be important indicators.

Clorox currently trades at $91.91, up from $89.90 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.